As of 2026-09-13, the Relative Valuation of Mersana Therapeutics Inc (MRSN) is (374.23) USD. This relative valuation is based on P/E multiples. With the latest stock price at 29.08 USD, the upside of Mersana Therapeutics Inc based on Relative Valuation is -1386.9%.
The range of the Relative Valuation is (327.98) - (416.28) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 23.3x - 29.7x | 26.5x |
| Forward P/E multiples | 23.4x - 30.4x | 26.9x |
| Fair Price | (327.98) - (416.28) | (374.23) |
| Upside | -1227.9% - -1531.5% | -1386.9% |
| Date | P/E |